Skip to Main Content

Author Details

Manuela Krumbholz
University Hospital Erlangen
2006
38
13
Nathan Sheffield (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
37706343Somatic variant profiling in chronic phase pediatric chronic myeloid leukemia.Haematologica2024
36899075Temporal evolution and differential patterns of cellular reconstitution after therapy for childhood cancers.Sci Rep2023
38012567Synergistic lethality in chronic myeloid leukemia - targeting oxidative phosphorylation and unfolded protein response effectively complements tyrosine kinase inhibitor treatment.BMC Cancer2023
37875583Continuous therapy response references for BCR::ABL1 monitoring in pediatric chronic myeloid leukemia.Sci Rep2023
36707619Management of children and adolescents with chronic myeloid leukemia in blast phase: International pediatric CML expert panel recommendations.Leukemia2023
36602564Effects of the STAMP-inhibitor asciminib on T cell activation and metabolic fitness compared to tyrosine kinase inhibition by imatinib, dasatinib, and nilotinib.Cancer Immunol Immunother2023
36276159Patient-reported long-term outcome following allogeneic hematopoietic stem cell transplantation in pediatric chronic myeloid leukemia.Front Oncol2022
35406484The Cytogenetic Landscape of Pediatric Chronic Myeloid Leukemia Diagnosed in Chronic Phase.Cancers (Basel)2022
36591451Corrigendum: Patient-reported long-term outcome following allogeneic hematopoietic stem cell transplantation in pediatric chronic myeloid leukemia.Front Oncol2022
33326092Liquid Biopsies in Ewing Sarcoma.Methods Mol Biol2021
34426444Quantification of Translocation-Specific ctDNA Provides an Integrating Parameter for Early Assessment of Treatment Response and Risk Stratification in Ewing Sarcoma.Clin Cancer Res2021
34050156Multimodal analysis of cell-free DNA whole-genome sequencing for pediatric cancers with low mutational burden.Nat Commun2021
32881892Low-frequency variation near common germline susceptibility loci are associated with risk of Ewing sarcoma.PLoS One2020
32052098Correction to: Assessment of treatment responses in children and adolescents with Ewing sarcoma with metabolic tumor parameters derived from <sup>18</sup>F-FDG-PET/CT and circulating tumor DNA.Eur J Nucl Med Mol Imaging2020
31853559Assessment of treatment responses in children and adolescents with Ewing sarcoma with metabolic tumor parameters derived from <sup>18</sup>F-FDG-PET/CT and circulating tumor DNA.Eur J Nucl Med Mol Imaging2020
33047515Sarcoma treatment in the era of molecular medicine.EMBO Mol Med2020
31034759High sensitivity and clonal stability of the genomic fusion as single marker for response monitoring in ETV6-RUNX1-positive acute lymphoblastic leukemia.Pediatr Blood Cancer2019
31915468Molecular Composition of Genomic <i>TMPRSS2-ERG</i> Rearrangements in Prostate Cancer.Dis Markers2019
31199062Large amplicon droplet digital PCR for DNA-based monitoring of pediatric chronic myeloid leukaemia.J Cell Mol Med2019
29925908Front-line imatinib treatment in children and adolescents with chronic myeloid leukemia: results from a phase III trial.Leukemia2018
29899875Characterization and diagnostic application of genomic <i>NPM-ALK</i> fusion sequences in anaplastic large-cell lymphoma.Oncotarget2018
27283964Genomic EWSR1 Fusion Sequence as Highly Sensitive and Dynamic Plasma Tumor Marker in Ewing Sarcoma.Clin Cancer Res2016
24884312Response monitoring of infant acute myeloid leukemia treatment by quantification of the tumor specific MLL-FNBP1 fusion gene.Leuk Lymphoma2015
26146805From initiation to eradication: the lifespan of an MLL-rearranged therapy-related paediatric AML.Bone Marrow Transplant2015
24673583DNA copy number alterations mark disease progression in paediatric chronic myeloid leukaemia.Br J Haematol2014
24810322Sustained complete molecular remission after imatinib discontinuation in children with chronic myeloid leukemia.Pediatr Blood Cancer2014
23127356Identification of the genomic BCR-ABL1 fusion sequence from blood specimen stored on filter paper.Leuk Res2013
23441188Genomic EWS-FLI1 fusion sequences in Ewing sarcoma resemble breakpoint characteristics of immature lymphoid malignancies.PLoS One2013
23042018Novel MLL2 mutation in Kabuki syndrome with hypogammaglobulinemia and severe chronic thrombopenia.J Pediatr Hematol Oncol2013
22887688Genomic BCR-ABL1 breakpoints in pediatric chronic myeloid leukemia.Genes Chromosomes Cancer2012
20164851Bimodal distribution of genomic MLL breakpoints in infant acute lymphoblastic leukemia treatment.Leukemia2010
20706703Intracellular ROS level is increased in fibroblasts of triple A syndrome patients.J Mol Med (Berl)2010
19081626Cluster analysis of genomic ETV6-RUNX1 (TEL-AML1) fusion sites in childhood acute lymphoblastic leukemia.Leuk Res2009
18172684Three siblings with triple A syndrome with a novel frameshift mutation in the AAAS gene and a review of 17 independent patients with the frequent p.Ser263Pro mutation.Eur J Pediatr2008
18953174Late-onset triple A syndrome: a risk of overlooked or delayed diagnosis and management.Horm Res2008
18628786Axonal neuropathy with unusual pattern of amyotrophy and alacrima associated with a novel AAAS mutation p.Leu430Phe.Eur J Hum Genet2008
18615337Triple A syndrome mimicking ALS.Amyotroph Lateral Scler2008
16609705Cellular localization of 17 natural mutant variants of ALADIN protein in triple A syndrome - shedding light on an unexpected splice mutation.Biochem Cell Biol2006
  • 1 - 38 of 38

Recommended Authors

University of Colorado School of Medicine
Career Start Year 2008
Number of shared co-authors 0
Hannover Medical School
Career Start Year 2007
Number of shared co-authors 2
Hospital Israelita Albert Einstein
Career Start Year 2007
Number of shared co-authors 0
The University of Texas MD Anderson Cancer Center
Career Start Year 2006
Number of shared co-authors 0
Semmelweis University
Career Start Year 2006
Number of shared co-authors 4
Saint-Louis Hospital
Career Start Year 2005
Number of shared co-authors 4
Clinical Research Division, Fred Hutchinson Cancer Research Center
Career Start Year 2003
Number of shared co-authors 1
Oregon Health & Science University
Career Start Year 2002
Number of shared co-authors 0
Universitatsklinikum Jena
Career Start Year 2002
Number of shared co-authors 1
Oncology R&D
Career Start Year 2002
Number of shared co-authors 1
St. Jude Children's Research Hospital
Career Start Year 2000
Number of shared co-authors 1
Children's Hospital of Philadelphia
Career Start Year 2000
Number of shared co-authors 0
University of Washington
Career Start Year 1998
Number of shared co-authors 6
Washington University School of Medicine in St. Louis
Career Start Year 1998
Number of shared co-authors 0
Children's Hospital Los Angeles
Career Start Year 1997
Number of shared co-authors 3
German Cancer Research Center (DKFZ), National Center for Tumor Diseases (NCT)
Career Start Year 1996
Number of shared co-authors 7
St Jude Children's Research Hospital
Career Start Year 1996
Number of shared co-authors 5
Mayo Clinic
Career Start Year 1995
Number of shared co-authors 1
Hannover Medical School
Career Start Year 1994
Number of shared co-authors 7
Hannover Medical School
Career Start Year 1993
Number of shared co-authors 2
Kyoto University
Career Start Year 1993
Number of shared co-authors 2
University of Paris
Career Start Year 1993
Number of shared co-authors 3
Baylor College of Medicine
Career Start Year 1992
Number of shared co-authors 18
Johns Hopkins University School of Medicine
Career Start Year 1992
Number of shared co-authors 0
The Hospital for Sick Children, University of Toronto
Career Start Year 1990
Number of shared co-authors 1
Lille University Hospital, INSERM UMR-S7, CNRS UMR9020, Lille University.
Career Start Year 1989
Number of shared co-authors 1
Fred Hutchinson Cancer Center
Career Start Year 1989
Number of shared co-authors 1
Toronto General Hospital, University Health Network, University of Toronto
Career Start Year 1988
Number of shared co-authors 0
Fred Hutchinson Cancer Research Centre
Career Start Year 1987
Number of shared co-authors 4
Taussig Cancer Institute, Cleveland Clinic
Career Start Year 1983
Number of shared co-authors 5

Collaborators

University Hospital Erlangen
Co-authored papers 27
University Hospital Essen, West German Cancer Center
Co-authored papers 7
Institute of Pathology, Friedrich-Alexander University Erlangen-Nurnberg (FAU)
Co-authored papers 6
St. Anna Children's Cancer Research Institute (CCRI)
Co-authored papers 3
Hannover Medical School
Co-authored papers 3
Balgrist University Hospital, University of Zurich (UZH)
Co-authored papers 2
Institut Curie
Co-authored papers 2
Institut Curie Hospital
Co-authored papers 2
Co-authored papers 2
St. Anna Children's Cancer Research Institute (CCRI)
Co-authored papers 2
St. Anna Children's Hospital, Medical University of Vienna
Co-authored papers 2
German Cancer Research Center
Co-authored papers 2
Centre Leon Berard & Universite Claude Bernard
Co-authored papers 2
St. Anna Children's Cancer Research Institute (CCRI)
Co-authored papers 2
University Children's Hospital Muenster
Co-authored papers 2
St. Anna Children's Cancer Research Institute (CCRI)
Co-authored papers 2
PSL Research University, Institut Curie Research Center, INSERM U, Institut Curie
Co-authored papers 2
University Hospital Essen, West German Cancer Center
Co-authored papers 2
University College London, Cancer Institute
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1
Technische Universitat Munchen
Co-authored papers 1
Co-authored papers 1
CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences
Co-authored papers 1
Cancer Center of Lyon
Co-authored papers 1
INSERM U830 Cancer, Institut Curie Research Center, PSL Research University
Co-authored papers 1
National Cancer Institute
Co-authored papers 1
CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences
Co-authored papers 1
National Cancer Institute, National Institutes of Health
Co-authored papers 1
Institut Curie
Co-authored papers 1